KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $16.16 $18.63 Friday, 26th Apr 2024 ACAD stock ended at $16.71. This is 2.45% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.92% from a day low at $16.27 to a day high of $16.74.
90 days $16.16 $27.94
52 weeks $16.16 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Apr 12, 2016 $32.24 $32.24 $32.24 $32.24 2 791 181
Apr 11, 2016 $31.11 $31.11 $31.11 $31.11 2 359 006
Apr 08, 2016 $31.78 $31.78 $31.78 $31.78 2 356 586
Apr 07, 2016 $32.26 $32.26 $32.26 $32.26 3 909 643
Apr 06, 2016 $32.86 $32.86 $32.86 $32.86 4 879 468
Apr 05, 2016 $29.90 $29.90 $29.90 $29.90 3 185 697
Apr 04, 2016 $30.06 $30.06 $30.06 $30.06 7 350 804
Apr 01, 2016 $28.66 $28.66 $28.66 $28.66 5 871 819
Mar 31, 2016 $27.96 $27.96 $27.96 $27.96 8 418 551
Mar 30, 2016 $25.74 $25.74 $25.74 $25.74 16 047 671
Mar 29, 2016 $23.81 $23.81 $23.81 $23.81 0
Mar 28, 2016 $23.81 $23.81 $23.81 $23.81 13 996 200
Mar 24, 2016 $20.31 $20.31 $20.31 $20.31 2 308 000
Mar 23, 2016 $20.25 $20.25 $20.25 $20.25 3 982 600
Mar 22, 2016 $22.64 $22.64 $22.64 $22.64 3 131 500
Mar 21, 2016 $21.53 $21.53 $21.53 $21.53 2 924 700
Mar 18, 2016 $19.79 $19.79 $19.79 $19.79 2 976 600
Mar 17, 2016 $19.53 $19.53 $19.53 $19.53 1 952 300
Mar 16, 2016 $19.39 $19.39 $19.39 $19.39 1 648 100
Mar 15, 2016 $19.65 $19.65 $19.65 $19.65 1 638 000
Mar 14, 2016 $20.32 $20.32 $20.32 $20.32 1 945 700
Mar 11, 2016 $20.19 $20.19 $20.19 $20.19 1 733 200
Mar 10, 2016 $19.26 $19.26 $19.26 $19.26 1 571 000
Mar 09, 2016 $19.35 $19.35 $19.35 $19.35 1 976 700
Mar 08, 2016 $19.60 $19.60 $19.60 $19.60 1 955 100
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT